Literature DB >> 31179775

Guanidine-based disinfectants, polyhexamethylene guanidine-phosphate (PHMG-P), polyhexamethylene biguanide (PHMB), and oligo(2-(2-ethoxy)ethoxyethyl guanidinium chloride (PGH) induced epithelial-mesenchymal transition in A549 alveolar epithelial cells.

Yong Joo Park1, Mi Ho Jeong1, In Jae Bang1, Ha Ryong Kim2, Kyu Hyuck Chung1.   

Abstract

Abstracts Objective: The major active ingredient of humidifier disinfectant, polyhexamethylene guanidine-phosphate (PHMG-P), caused hundreds of deaths with pulmonary fibrosis. However, structurally similar guanidine-based disinfectants are still in use in various fields. Moreover, as they are precursors of excellent antimicrobial compounds, new chemicals with guanidine-based structures have been synthesized and introduced. In this study, we evaluated pulmonary fibrotic responses induced by PHMG-P, polyhexamethylene biguanide (PHMB), and oligo(2-(2-ethoxy)ethoxyethyl guanidinium chloride (PGH) and their toxicity mechanisms in type II alveolar epithelial A549 cells. Materials and methods: Cellular damage was compared by using the cytotoxicity test (WST-1 assay) and plasma membrane toxicity tests (Lactate dehydrogenase leakage detection assay and plasma membrane staining). As a measure of fibrotic response, induction of the epithelial-mesenchymal transition (EMT) was evaluated by measuring E-cadherin and α-smooth muscle actin (α-SMA) protein expression (epithelial and mesenchymal marker, respectively).
Results: All tested compounds showed membrane damage; PHMG-P and PGH induced the highest and lowest damage, respectively. Moreover, they induced EMT when the test chemicals were treated with similar cytotoxic concentrations. Conclusions: Our study indicates that three guanidine-based disinfectants are potential fibrosis-inducing chemicals that induce EMT through cellular damage. Therefore, use of guanidine-based polymers should be strictly regulated by considering their potential adverse effects on the lungs.

Entities:  

Keywords:  Guanidine-based disinfectant; cellular damage; epithelial-mesenchymal transition; pulmonary fibrosis

Mesh:

Substances:

Year:  2019        PMID: 31179775     DOI: 10.1080/08958378.2019.1624896

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  9 in total

Review 1.  Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision Medicine.

Authors:  Mi Ho Jeong; Hongwei Han; David Lagares; Hyungsoon Im
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-20

2.  Effects of lipid membrane composition on the distribution of biocidal guanidine oligomer with solid supported lipid membranes.

Authors:  Yeonjeong Ha; Jung-Hwan Kwon
Journal:  RSC Adv       Date:  2020-06-10       Impact factor: 4.036

Review 3.  Antifungal Polymeric Materials and Nanocomposites.

Authors:  Winnie Ntow-Boahene; David Cook; Liam Good
Journal:  Front Bioeng Biotechnol       Date:  2021-12-24

Review 4.  Anti-COVID-19 Nanomaterials: Directions to Improve Prevention, Diagnosis, and Treatment.

Authors:  Mohammad Souri; Mohsen Chiani; Ali Farhangi; Mohammad Reza Mehrabi; Dariush Nourouzian; Kaamran Raahemifar; M Soltani
Journal:  Nanomaterials (Basel)       Date:  2022-02-25       Impact factor: 5.076

5.  Analysis of lung cancer-related genetic changes in long-term and low-dose polyhexamethylene guanidine phosphate (PHMG-p) treated human pulmonary alveolar epithelial cells.

Authors:  Hong Lee; Sang Hoon Jeong; Hyejin Lee; Cherry Kim; Yoon Jeong Nam; Ja Young Kang; Myeong Ok Song; Jin Young Choi; Jaeyoung Kim; Eun-Kee Park; Yong-Wook Baek; Ju-Han Lee
Journal:  BMC Pharmacol Toxicol       Date:  2022-03-30       Impact factor: 2.483

6.  Liposome leakage and increased cellular permeability induced by guanidine-based oligomers: effects of liposome composition on liposome leakage and human lung epithelial barrier permeability.

Authors:  Yeonjeong Ha; Yerim Koo; Seon-Kyung Park; Ga-Eun Kim; Han Bin Oh; Ha Ryong Kim; Jung-Hwan Kwon
Journal:  RSC Adv       Date:  2021-09-28       Impact factor: 4.036

7.  New-Onset and Exacerbation of Lung Diseases after Short-Term Exposures to Humidifier Disinfectant during Hospitalization.

Authors:  Seula Lee; Kyunghee Han; Jeonggyo Yoon; Eun-Kyung Jo; Wonho Yang; Yoon-Hyeong Choi
Journal:  Toxics       Date:  2022-07-04

Review 8.  Health Effects Associated With Humidifier Disinfectant Use: A Systematic Review for Exploration.

Authors:  Ji-Hun Song; Joonho Ahn; Min Young Park; Jaeyoung Park; Yu Min Lee; Jun-Pyo Myong; Jung-Wan Koo; Jongin Lee
Journal:  J Korean Med Sci       Date:  2022-08-22       Impact factor: 5.354

9.  Humidifier Disinfectant Consumption and Humidifier Disinfectant-Associated Lung Injury in South Korea: A Nationwide Population-Based Study.

Authors:  Jeonggyo Yoon; Minsun Kang; Jaehun Jung; Min Jae Ju; Sung Hwan Jeong; Wonho Yang; Yoon-Hyeong Choi
Journal:  Int J Environ Res Public Health       Date:  2021-06-06       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.